Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2021 09:00 ET | Source: EnsembleIQ

EnsembleIQ BrandLab, Honored Among Peers as ‘Digital Team of The Year,’ Expands to Fulfill B2B Demand for Comprehensive Creative Agency

CHICAGO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Leading business media, insights and networking event provider EnsembleIQ is scaling up its award-winning EIQ BrandLab marketing division into an...
December 06, 2021 08:00 ET | Source: Oncocyte Corporation

Oncocyte Corporation Hosting Business Update Call

IRVINE, Calif., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics and monitoring company with the mission to improve patient outcomes by providing clear...
December 06, 2021 08:00 ET | Source: Olink Proteomics AB

Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Proteomics

UPPSALA,Sweden, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced a new publication on Olink’s PEA technology, providing an invaluable resource to the...
December 06, 2021 08:00 ET | Source: Olink Proteomics AB

Innovation and transparency at the heart of Olink’s culture – details of the technology behind the Olink Explore high-throughput proteomics platform published in the journal, Molecular & Cellular Proteomics

UPPSALA, Sweden, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced a new publication on Olink’s PEA technology, providing an invaluable resource to the...
December 06, 2021 08:00 ET | Source: TFF Pharmaceuticals, Inc.

TFF Pharmaceuticals Hosting Science Day on December 13, 2021

AUSTIN, Texas, Dec. 06, 2021 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug...
December 06, 2021 08:00 ET | Source: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals and RareStone Ltd. Announce Exclusive Licensing Agreement for the Development and Commercialization of IMCIVREE (setmelanotide) in China

-- RareStone to seek marketing authorization for IMCIVREE to treat obesity due to biallelic POMC, PCSK1 and LEPR deficiencies and Bardet-Biedl and Alström syndromes in mainland China, Hong Kong and...
December 06, 2021 07:18 ET | Source: Research and Markets

World Engineering Microorganisms into Powerful Micromachines Market Study 2021: Can Synthetic Biology Foster Bio-Revolution?

Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution??" report has been added to...
December 06, 2021 07:00 ET | Source: Kronos Bio, Inc.

Kronos Bio Announces First Patient Dosed in AGILITY Phase 3 Clinical Trial of Entospletinib in Patients With Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia

Data in the second half of 2023 could potentially lead to accelerated approvalIf approved, entospletinib would be the first treatment for newly diagnosed patients with the NPM1 mutation who are fit...
December 06, 2021 06:30 ET | Source: Matinas BioPharma Holdings, Inc.

Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer

BEDMINSTER, N.J., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on improving the intracellular delivery of...
December 04, 2021 05:00 ET | Source: Bragar Eagel & Squire

GINKGO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ginkgo Bioworks Holdings, Inc. and Encourages Investors to Contact the Firm

NEW YORK, Dec. 04, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against...